Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.81 - $4.84 $42,150 - $72,600
-15,000 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$4.74 - $9.91 $14,220 - $29,730
3,000 Added 25.0%
15,000 $74,000
Q4 2021

Feb 08, 2022

BUY
$5.86 - $13.52 $70,320 - $162,240
12,000 New
12,000 $121,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.09B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Inter Ocean Capital Group, LLC Portfolio

Follow Inter Ocean Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inter Ocean Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inter Ocean Capital Group, LLC with notifications on news.